← Product Code [DSA](/productcode/DSA) · K132253 # REMOVABLE PATIENT LEADS ECG CABLE (K132253) _Boston Scientific · DSA · Dec 16, 2013 · Cardiovascular · SESE_ **Canonical URL:** https://fda-staging.innolitics.com/device/K132253 ## Device Facts - **Applicant:** Boston Scientific - **Product Code:** [DSA](/productcode/DSA.md) - **Decision Date:** Dec 16, 2013 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 870.2900 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular ## Indications for Use The BSC Removable Patient Leads ECG Cable is used to transmit signals from patient-connected electrodes or transducers to electrocardiograph recorders/monitors for both diagnostic and monitoring purposes. ECG cables are supplied non-sterile and are not sterilizable; they are reusable devices and are recommended to be used by trained operators in a medical environment. Use is limited by the indications for use of the connected monitoring or diagnostic equipment. ## Device Story The Removable Patient Leads ECG Cable (Model 6750) is a passive accessory used to transmit electrical ECG signals from patient-affixed electrodes to an external Boston Scientific programming system or ECG monitor. The device consists of five leadwires with patient clips that connect to electrodes on the patient's chest wall and extremities, and a trunk cable that connects to the monitor via a 6-pin DIN AAMI connector. It is a reusable, non-sterile device intended for use by trained clinicians in medical environments. The cable facilitates the display of ECG data on a monitor, assisting healthcare providers in diagnostic and monitoring tasks. It does not perform signal processing or analysis; it serves solely as a physical conduit for electrical signals. ## Clinical Evidence Bench testing only. Performance data included electromagnetic compatibility, electrical safety, and biocompatibility testing to support substantial equivalence. ## Technological Characteristics Passive ECG cable; 5 leadwires; 6-pin DIN AAMI connector; 120-inch trunk cable; 40-inch leadwires. Materials: Polyvinyl Chloride (PVC), Santoprene, Elastollan. Complies with ANSI/AAMI/IEC 60601-2-27 for leadwire colors. Non-sterile, non-sterilizable, reusable. No software or active electronic components. ## Regulatory Identification A patient transducer and electrode cable (including connector) is an electrical conductor used to transmit signals from, or power or excitation signals to, patient-connected electrodes or transducers. ## Predicate Devices - ECG Patient Cables & Lead Wire System ([K771645](/device/K771645.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ ·DEC 16 2013 ### K132253 BOSTON SCIENTIFIC REMOVABLE PATIENT LEADS ECG CABLE # 2. 510(K) SUMMARY #### 2.1. GENERAL INFORMATION | Device Common/Usual
Generic Name: | ECG Cable | |---------------------------------------|----------------------------------------------------------------------------------------------------------------------------| | Device Trade Name: | Removable Patient Leads ECG Cable | | Applicant's Name and
Address: | Boston Scientific Corporation
4100 Hamline Avenue North
St. Paul, Minnesota 55112-5798
ERN: 2124215 | | Product Code/
Regulation Citation: | DSA, Cardiovascular
21 CFR 870.2900 | | Contact Name and
Information: | Melissa Klamerus
Regulatory Specialist
Phone: 651.582.6771
Fax: 651.582.5134
E-mail: melissa.klamerus@bsci.com | | Owner /Operator: | Boston Scientific Corporation
One Boston Scientific Place
Natick, MA 01760
ERN: 9912058 | | Manufacturing
Facility: | Technical Services for Electronics Inc. (TSE)
2f No. 21 Jian Kang Road
Chung Ho City Taiwan
ERN: 3008483389 | #### 2.2. DEVICE Removable Patient Leads ECG Cable. #### 2.3. PREDICATE DEVICE ECG Patient Cables & Lead Wire System, K771645 (Oct 13, 1977). Property of Boston Scientific Corporation Confidential. Do not Copy July 2013 2-1 {1}------------------------------------------------ #### 2.4. DEVICE DESCRIPTION The BSC ECG cable, model 6750 is an external device used to transmit ECG signals from electrodes which are affixed to the patient's body to an external BSC programming system that includes an ECG display monitor. Each leadwire clip is attached to ECG patient electrodes. The other end of the leadwire plugs into one end of the trunk cable. The trunk cable then plugs into the BSC programming system. #### 2.5. INDICATIONS FOR USE The Removable Patient Leads ECG Cable is used to transmit signals from patient-connected electrodes or transducers to electrocardiograph recorders/monitors for both diagnostic and monitoring purposes. ECG cables are supplied non-sterile and are not sterilizable; they are reusable devices and are recommended to be used by trained operators in a medical environment. Use is limited by the indications for use of the connected monitoring or diagnostic equipment. #### 2.6. DEVICE COMPARISON TO PREDICATE The BSC ECG cable incorporates substantially equivalent design, packaging, fundamental technology, and indications for use as the predicate, ECG Patient Cables & Lead Wire System (K771645). See Table 2-1 for a comparison between the BSC ECG cable and the predicate device. | Characteristic | BSC ECG Cable | Tyco predicate device | |---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Indications for use | ECG cable is used to transmit
signals from patient-connected
electrodes or transducers to
electrocardiograph
recorders/monitors for both
diagnostic and monitoring
purposes. | ECG leadwire is used to transmit
signals from patient-connected
electrodes or transducers to
electrocardiograph
recorders/monitors for both
diagnostic and monitoring
purposes. | | Patient usage | Reusable | Reusable | | Sterility | Supplied non-sterile; cannot be
sterilized | Supplied non-sterile; cannot be
sterilized | | Anatomical sites | Attached to electrodes placed at
standard specified locations on
chest wall and extremities | Attached to electrodes placed at
standard specified locations on
chest wall and extremities | | Functionality | transmit signals from 5 patient-
connected leadwires | transmit signals from 5 patient-
connected leadwires | | | | Table 2-1: Comparison between BSC ECG cable and predicate device | |--|--|------------------------------------------------------------------| | | | | Property of Boston Scientific Corporation Confidential. Do not Copy July 2013 {2}------------------------------------------------ ### K132253 BOSTON SCIENTIFIC REMOVABLE PATIENT LEADS ECG CARLE TRADITIONAL 510(K) | Design/
Appearance | Number of leadwires
(patient wire) | 5 | 5 | |-----------------------|---------------------------------------------------|----------------------------------------------------------|----------------------------------------------------------| | | Trunk cable length | $120 \pm 6$ inches | $120 \pm 6$ inches | | | Leadwire length
(each) | $40 \pm 1.5$ inches | $40 \pm 1.5$ inches | | | Connector - Patient
end | patient clip | patient clip | | | Connector - Monitor
end | 6 pin DIN AAMI | 6 pin DIN AAMI | | | Packaging | outer labeled box inner labeled bubble pouch non-sterile | outer labeled box inner labeled bubble pouch non-sterile | | | Leadwire colors
(ANSI/AAMI/
IEC 60601-2-27) | white green brown red black | white green brown red black | | | Cable Coating
Materials | Polyvinyl Chloride (PVC) Santoprene Elastollan | Polyvinyl Chloride (PVC) Santoprene | #### 2.7. PERFORMANCE DATA Electromagnetic compatibility, electrical safety, biocompatibility and bench testing were performed to support a determination of substantial equivalence. The results of these tests provide reasonable assurance that the proposed device design meets the performance requirements and performs as intended. No new safety or performance issues were found during device testing, #### 2.8. CONCLUSION . Based on the indications for use, technological characteristics, and safety and performance testing, the Removable Patient Leads ECG Cable has been shown to be appropriate for its indications for use and is considered to be substantially equivalent to the predicate ECG cable, K771645. {3}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized graphic of an abstract human figure with outstretched arms, accompanied by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the graphic. The text is in a circular format, with the graphic positioned in the center. Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 December 16, 2013 Boston Scientific Cardiac Rhythm Management Ms. Melissa Klamerus 4100 Hamline Avenue North St. Paul, MN 55112 Re: K132253 Trade/Device Name: Boston Scientific Removable Patient Leads ECG Cable, Model 6750 Regulatory Number: 21 CFR 870.2900 Regulation Name: Patient Transducer and Electrode Cable (including Connector) Regulatory Class: Class II (Two) Product Code: DSA Dated: November 14, 2013 Received: November 15, 2013 Dear Ms. Klamerus: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {4}------------------------------------------------ Page 2 - Ms. Melissa Klamerus Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm 1 15809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours. **Owen-P. Faris -S** for Bram D. Zuckerman Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ K132253 Boston Scientific Removable Patient Leads ECG Cable Traditional 510(k) APPENDIX 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ## Indications for Use Statement | 510(k) Number
(if known) | | |-----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Device Name | Removable Patient Leads ECG Cable | | Indications for
Use | The BSC Removable Patient Leads ECG Cable is used to transmit
signals from patient-connected electrodes or transducers to
electrocardiograph recorders/monitors for both diagnostic and
monitoring purposes. ECG cables are supplied non-sterile and are
not sterilizable; they are reusable devices and are recommended to
be used by trained operators in a medical environment. Use is
limited by the indications for use of the connected monitoring or
diagnostic equipment. | Prescription Use _ × (Per 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (Per 21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) ## Concurrence of CDRH, Office of Device Evaluation (ODE) Clive Z. Digitally signed by Owen P. Faris -5 Date: 2013. 12.16 16:21:28 -05'00' --- **Source:** [https://fda-staging.innolitics.com/device/K132253](https://fda-staging.innolitics.com/device/K132253) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com